Picture of Beigene logo

BGNE Beigene Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapFalling Star

Annual income statement for Beigene, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUSPROSPECTUSARSARS
Standards:
CAS
CAS
CAS
CAS
CAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue1,3102,9542,1207,5899,566
Cost of Revenue
Gross Profit1,1202,4631,6346,5287,663
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses6,0669,70613,36717,16822,992
Operating Profit-4,756-6,752-11,247-9,580-13,425
Other Net Non Operating Costs
Net Income Before Taxes-4,755-6,753-11,249-9,579-13,427
Provision for Income Taxes
Net Income After Taxes-4,748-6,928-11,407-9,748-13,642
Minority Interest
Net Income Before Extraordinary Items
Net Income-4,747-6,915-11,384-9,748-13,642
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-4,747-6,915-11,384-9,748-13,642
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-3.56-5.18-8.53-7.3-10.2
Dividends per Share